Lee Mong-Hong, Lozano Guillermina
Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA.
Semin Cancer Biol. 2006 Jun;16(3):225-34. doi: 10.1016/j.semcancer.2006.03.009. Epub 2006 Apr 6.
The 14-3-3 sigma (sigma) protein, a unique member of 14-3-3 family, is a negative regulator of the cell cycle and is induced by p53 to initiate cell cycle checkpoint control after DNA damage. Among the 14-3-3 family members, 14-3-3 sigma is uniquely induced by p53 and has a positive feedback effect on p53 activity in response to DNA damage. Although 14-3-3 sigma is linked to p53-regulated cell cycle checkpoint control, the detailed mechanisms of cell cycle regulation by 14-3-3 sigma remain unclear. Decreased expression of 14-3-3 sigma was reported in several types of carcinomas, suggesting that the negative regulatory role of 14-3-3 sigma in the cell cycle is compromised during tumorigenesis. Given the fact that p53's tumor suppressive function is lost in almost half of all human cancers and that 14-3-3 sigma's activity is linked to the p53 network, a perspective regarding the p53/14-3-3 sigma relationship is needed for cancer research. Here we discuss the mechanisms by which 14-3-3 sigma-stabilizes p53 with the hope that these insights may be applied to develop targeted therapeutic strategies for cancer treatment.
14-3-3σ蛋白是14-3-3家族的独特成员,是细胞周期的负调控因子,在DNA损伤后由p53诱导启动细胞周期检查点控制。在14-3-3家族成员中,14-3-3σ蛋白是唯一由p53诱导产生的,并且在响应DNA损伤时对p53活性具有正反馈作用。尽管14-3-3σ蛋白与p53调控的细胞周期检查点控制有关,但其调控细胞周期的详细机制仍不清楚。据报道,在几种类型的癌症中14-3-3σ蛋白的表达降低,这表明在肿瘤发生过程中14-3-3σ蛋白在细胞周期中的负调控作用受到损害。鉴于几乎一半的人类癌症中p53的肿瘤抑制功能丧失,且14-3-3σ蛋白的活性与p53网络相关,癌症研究需要一种关于p53/14-3-3σ蛋白关系的观点。在此,我们讨论14-3-3σ蛋白稳定p53的机制,希望这些见解可应用于开发癌症治疗的靶向治疗策略。